Skip to main content

Nourish

Category: AI in Healthcare

Nourish is the largest dietitian-led metabolic health clinic in the US, combining AI-powered technology with registered dietitians to deliver insurance-covered virtual nutrition care. Nourish was founded in 2021. The company is led by Aidan Dewar. Based in New York, New York, United States. Team size: 1000+. Total funding raised: $215M. Latest round: Series C. Key investors include Menlo Ventures; J.P. Morgan Growth Equity Partners; Index Ventures; Thrive Capital; Y Combinator; Maverick Ventures; Atomico; BoxGroup; G Squared; Daybreak; Operator Partners; TCV; Susa Ventures; Pinegrove Opportunity Partners.

Founded
2021
Headquarters
New York, New York, United States
Team size
1000+
Total funding
$215M

Value proposition

AI-powered, insurance-covered virtual nutrition care that pairs patients with Registered Dietitians to treat chronic disease through lifestyle change, with 94% of patients paying $0 out of pocket.

Products and solutions

AI-powered virtual nutrition counseling platform connecting patients with Registered Dietitians; AI health agent (24/7 patient coach for meal planning, lab interpretation, scheduling, goal tracking); AI copilot for dietitians (automated scribe, clinical insights, treatment recommendations); Mobile app with meal tracking, goal setting, and messaging; GLP-1 medication management program; Lab testing integration; Physician-led metabolic health clinic (expanding)

Unique value

Largest dietitian-led metabolic health clinic in the US combining 10,000+ RDs with AI agents, covered by insurance (94% pay $0), delivering clinically validated outcomes — patients on GLP-1s lose 33% more weight when paired with a Nourish RD.

Target customer

Patients with nutrition-related chronic conditions (obesity, diabetes, heart disease, GI conditions, eating disorders, cancer, autoimmune) covered by Medicare, Medicaid, and major commercial insurance plans; also employers and health systems seeking nutrition benefits.

Industries served

Healthcare / Telehealth / Nutrition / Metabolic Health / Chronic Disease Management / Employer Wellness

Technology advantage

AI-native platform with patient-facing AI health agents and provider AI copilots; largest W-2 Registered Dietitian network in the US (10,000+); insurance coverage across hundreds of plans covering 200M+ lives; integrated GLP-1 management, lab testing, and physician care; proprietary clinical outcomes data showing superior results vs. benchmarks; profitable since 2025.

How they differentiate

Differentiates via (1) nutrition-first, dietitian-led model vs. medication-first competitors, (2) largest RD network nationally (10,000+), (3) AI-native platform with agents for both patients and providers, (4) broad insurance coverage (200M+ lives, 94% pay $0), (5) integrated metabolic clinic adding physicians, labs, and GLP-1 prescribing, (6) proven clinical outcomes with peer-reviewed data.

Main competitors

Season Health; Foodsmart; Fay; Oviva; Noom; Omada Health; Calibrate; Found

Key partnerships

Hundreds of health plan partnerships covering 200M+ lives (including Aetna, BCBS, Cigna, Humana, UnitedHealthcare, Medicare, Medicaid); 250+ health system referral partnerships; employer benefit partnerships; Y Combinator (W21 batch).

Notable customers

Partners with hundreds of health plans covering 200M+ lives (including major national commercial, Medicare, and Medicaid plans); 250+ health system referral partnerships; partnerships with large employer accounts via payer contacts. Specific named customers not publicly disclosed.

Major milestones

2021: Founded & graduated Y Combinator W21 batch; 2023: $8M Seed round led by Thrive Capital; 2024: $35M Series A led by Index Ventures; 2025: $70M Series B led by J.P. Morgan, reached unicorn status ($1B+ valuation), profitable; 2026: $100M Series C led by Menlo Ventures at $1.75B valuation, expanded to physician-led metabolic clinic.

Growth metrics

10,000+ Registered Dietitians; 200M+ covered lives through payer partnerships; $1.75B valuation; profitable since 2025; 94% of patients pay $0; 68% six-month GLP-1 persistence rate; 33% greater weight loss for GLP-1 patients vs non-Nourish; 80% of patients see health improvements in 30 days.

Market positioning

Leading AI-native metabolic health clinic in the US, valued at $1.75B, with the largest dietitian network and broadest payer coverage in the country. Positioned at the intersection of the GLP-1 boom and chronic disease management market.

Geographic focus

United States (all 50 states)

About Aidan Dewar

Bain & Company (Associate Consultant); L Catterton; Goldman Sachs; Feed the Front Line. Harvard University, B.A. in Economics (Cum Laude).

Official website: